New Edge Advisors, LLC Kamada LTD Transaction History
New Edge Advisors, LLC
- $18.3 Billion
- Q2 2025
A detailed history of New Edge Advisors, LLC transactions in Kamada LTD stock. As of the latest transaction made, New Edge Advisors, LLC holds 50,543 shares of KMDA stock, worth $378,061. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,543
Previous 51,661
2.16%
Holding current value
$378,061
Previous $341,000
14.66%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding KMDA
# of Institutions
41Shares Held
5.8MCall Options Held
21KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$12.4 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$6.22 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA610KShares$4.57 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3330KShares$2.47 Million0.18% of portfolio
-
Essex Investment Management CO LLC Boston, MA324KShares$2.42 Million0.52% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $335M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...